CASI
CASI Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
3.23 / 10Overall Score
NeturalInvestment Rating
3.23 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of CASI
- Based on a composite score of 3.23/10, we rate CASI as a Netural. Our analysis breaks down into 3.51/10 for Fundamentals, 1.29/10 for Technicals, and 4.06/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of CASI?
Is CASI undervalued or overvalued?
Is money flowing into or out of CASI?
Trend Analysis of CASI
- Based on a composite score of 3.23/10, we rate CASI as a Netural. Our analysis breaks down into 3.51/10 for Fundamentals, 1.29/10 for Technicals, and 4.06/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is CASI undervalued or overvalued?
Technical Analysis of CASI?
Is money flowing into or out of CASI?
